These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8978311)

  • 1. Biological pattern of AML-M0 versus AML-M1: response.
    Venditti A; Del Poeta G; Buccisano F; Tamburini A; Aronica G; Bruno A; Cox-Froncillo MC; Maffei L; Simone MD; Papa G; Amadori S
    Blood; 1997 Jan; 89(1):345-6. PubMed ID: 8978311
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-M0) and its clinical implications.
    Venditti A; Del Poeta G; Stasi R; Buccisano F; Aronica G; Bruno A; Cox C; Maffei L; Tamburini A; Papa G; Amadori S
    Blood; 1996 Jan; 87(1):418-20. PubMed ID: 8547674
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9.
    Matutes E; Rodriguez B; Polli N; Tavares de Castro J; Parreira A; Andrews C; Griffin JD; Tindle RW; Catovsky D
    Hematol Oncol; 1985; 3(3):179-86. PubMed ID: 3862640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia.
    Pombo de Oliveira MS; Matutes E; Rani S; Morilla R; Catovsky D
    Acta Haematol; 1988; 80(2):61-4. PubMed ID: 2901804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the hemoglobin scavenger receptor (CD163/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia.
    Walter RB; Bächli EB; Schaer DJ; Rüegg R; Schoedon G
    Blood; 2003 May; 101(9):3755-6. PubMed ID: 12707228
    [No Abstract]   [Full Text] [Related]  

  • 6. Biphenotypic M0 acute myeloid leukemia with trisomy-4.
    Keung YK; Kaplan B; Douer D
    Leuk Lymphoma; 1994 Jun; 14(1-2):181-4. PubMed ID: 7522717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-M0) using in situ hybridization.
    Traweek ST; Liu J; Braziel RM; Johnson RM; Byrnes RK
    Diagn Mol Pathol; 1995 Sep; 4(3):212-9. PubMed ID: 7493141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocytic sarcoma preceding AML M0 and the diagnostic value of CD34.
    Astall E; Yarranton H; Arno J; Marcus R
    J Clin Pathol; 1999 Sep; 52(9):705-7. PubMed ID: 10655997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of childhood acute myeloid leukemia.
    Behm FG
    Clin Lab Med; 1999 Mar; 19(1):187-237, vii. PubMed ID: 10403081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular characteristics of acute myeloblastic leukemia associated with t(8;21)(q22;q22). The Japanese Cooperative Group of Leukemia/Lymphoma.
    Kita K; Shirakawa S; Kamada N
    Leuk Lymphoma; 1994 Apr; 13(3-4):229-34. PubMed ID: 8049646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute leukemia with extramedullary presentation and mixed myeloid and lymphoid expression.
    Bayle C; Romdhane NB; Bastard C; Vannier JP; Hayat M; Lemerle J; Bernard A
    Pediatr Hematol Oncol; 1986; 3(3):293-6. PubMed ID: 3153242
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
    Creutzig U; Harbott J; Sperling C; Ritter J; Zimmermann M; Löffler H; Riehm H; Schellong G; Ludwig WD
    Blood; 1995 Oct; 86(8):3097-108. PubMed ID: 7579404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modern classification of the acute non-lymphoblastic leukaemias.
    Hayhoe FG
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():70-2. PubMed ID: 2653522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE; Cruse JM; Webb RN; Sanders CM; Beason K
    Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic classification of acute myeloid leukemia: concordance among Eastern Cooperative Oncology Group investigators: a comment.
    Bennett JM; Cassileth PA; Paietta E; Rowe JM; Wiernik PH
    Leukemia; 1996 Aug; 10(8):1365. PubMed ID: 8709645
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphology, immunology, cytochemistry, and cytogenetics and the classification of subtypes in AML.
    Löffler H
    Haematol Blood Transfus; 1990; 33():239-42. PubMed ID: 2182416
    [No Abstract]   [Full Text] [Related]  

  • 17. Double marker analysis for terminal deoxynucleotidyl transferase and myeloid antigens in acute nonlymphocytic leukemia patients and healthy subjects.
    Adriaansen HJ; Hooijkaas H; Kappers-Klunne MC; Hählen K; van't Veer MB; van Dongen JJ
    Haematol Blood Transfus; 1990; 33():41-9. PubMed ID: 2323649
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia.
    Raife TJ; Lager DJ; Kemp JD; Dick FR
    Am J Clin Pathol; 1994 Mar; 101(3):296-9. PubMed ID: 7510927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.
    Suzuki R; Murata M; Kami M; Ohtake S; Asou N; Kodera Y; Tomonaga M; Masaki Y; Kusumoto S; Takeuchi J; Matsuda S; Hirai H; Yorimitsu mS; Hamajima N; Seto M; Shimoyama M; Ohno R; Morishima Y; Nakamura S
    Int J Hematol; 2003 Jun; 77(5):482-9. PubMed ID: 12841387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of acute biphenotypic leukemia.
    Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
    Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.